Cochlear’s earnings took a hit with a 62% profit drop, mostly due to weaker sales in the Middle East and China amid global market turbulence—but investors are betting on their long-term vision. CEO Dig Howitt is pushing the “medicalization” of hearing loss, framing it as a treatable condition like chronic disease, not just a lifestyle issue. Evidence linking untreated hearing loss to dementia and falls is accelerating adoption, especially for pediatric cases now standard care. Despite the dip, stock jumped over 7%, and they’re forecasting modest growth next year—betting big that more adults will seek medical solutions as science validates the urgency.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
